14/06/2026
The therapy is safe. The evidence is strong. Clinical trials at Johns Hopkins University, New York University, and St Vincent's Hospital Melbourne all reported strong efficacy and no significant adverse events.
The Therapeutic Goods Administration - TGA's own delegate acknowledged psilocybin-assisted therapy is well-tolerated and described by patients as "a compassionate tool that restores dignity and agency at the end of life." Yet terminally ill Australians still cannot access it.
The public consultation is open. Your submission directly influences the final decision.
Have your say before 3 July 2026 https://buff.ly/hwsQPWd
MMA’s latest media release can be found here: https://buff.ly/RanWEz5
For more information, visit: https://buff.ly/qwvjMWU